 ?您的位置：對(duì)照品 > 標(biāo)準(zhǔn)品 > 進(jìn)口標(biāo)準(zhǔn)品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：K570520 |
| 產(chǎn)品名稱：Ki 20227 |
| 產(chǎn)品CAS：623142-96-1 |
| 規(guī)格含量：5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
K570520 |
| 名稱: |
Ki 20227 |
| 別名: |
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]urea |
| CAS號(hào): |
623142-96-1 |
| 分子式: |
C??H??N?O?S |
| 分子量: |
480.54 |
| 種類: |
Standards; Enzyme Activators and Inhibitors; |
| 應(yīng)用: |
Ki 20227 is a c-fms tyrosine kinase inhibitor, which suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
